Clinical Trials Browser

Cancer Pain, Pain, Intractable

NCT06940570 2025-10-23

MATCH

Phase 3 Suspended

60 enrolled

Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT01567345 2024-08-02

PITAC

Phase NA Completed

54 enrolled

Agnosia, Neoplasms, Pain, Pain, Intractable

NCT05067257 2024-03-18

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Phase 2 Suspended

120 enrolled

Cancer Pain, Pain, Pain, Intractable

NCT01854229 2023-10-18

Prometra Post-Approval Study

Phase NA Completed

400 enrolled

Cancer Pain, Back Pain, Pain, Intractable, Chronic Pain

NCT00996983 2023-03-24

ZIDON

Phase 2 Unknown

16 enrolled

Neoplasms, Neuralgia, Pain, Pain, Intractable

NCT02484937 2022-06-29

Improving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians for Pain Pts

Phase NA Terminated

9 enrolled

Agnosia, Back Pain, Pain, Intractable, Chronic Pain

NCT04096391 2022-05-18

Prosper-001

Phase NA Completed

73 enrolled

Pain, Intractable, Chronic Pain

NCT04572776 2021-11-09

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Phase 3 Withdrawn

Cancer Pain, Pain, Pain, Intractable

NCT03639415 2021-03-08

Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

Phase 4 Withdrawn

Cancer Pain, Dizziness, Nausea, Pain, Intractable, Vomiting

NCT00381095 2021-01-20

COPE

Phase 4 Terminated

152 enrolled 14 charts

Sarcoma

Bone Neoplasms, Neoplasms, Pain, Intractable

NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

Phase NA Unknown

60 enrolled

Head & Neck

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

NCT03887494 2019-09-10

WAZA-ARY

Phase NA Unknown

15 enrolled

Hip Fractures, Pain, Intractable, Neoplasms, Bone Tissue

NCT03936205 2019-05-14

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Phase 2/3 Completed

18 enrolled

Neoplasm Metastasis, Pain, Intractable

NCT02036281 2018-05-15

A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

Phase 1 Completed

23 enrolled

Pain, Intractable

NCT01951911 2017-07-11

KETA-1

Phase 3 Withdrawn

Agnosia, Pain, Intractable

NCT02687347 2016-09-20

UDOME

Phase 3 Unknown

204 enrolled

Pain, Intractable

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Phase 2 Withdrawn

Other

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

NCT01291901 2014-08-08

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Phase 2 Completed

33 enrolled

Neoplasms, Pain, Pain, Intractable

NCT01326325 2013-08-07

KEPAL

Phase 3 Completed

24 enrolled

Neoplasms, Pain, Pain, Intractable

NCT00484484 2011-05-04

KETADOL

Phase 3 Completed

100 enrolled

Neoplasms, Pain, Pain, Intractable

NCT00216658 2011-01-24

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

Phase 2 Completed

87 enrolled

Cancer Pain, Pain, Intractable

Clinical Trials

Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

MATCH

PITAC

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Prometra Post-Approval Study

ZIDON

Improving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians for Pain Pts

Prosper-001

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

COPE

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

WAZA-ARY

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

KETA-1

UDOME

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

NP2 Enkephalin For Treatment of Intractable Cancer Pain

KEPAL

KETADOL

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -